Waltham, MA, United States of America

Paul Martha

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Interleukin Genetics, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Martha. Retrieved from https://idiyas.com/inventor/paul-martha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Martha: Innovator in Osteoporosis Diagnostics and Therapeutics

Introduction

Paul Martha is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of osteoporosis through his innovative work in diagnostics and therapeutics. His research focuses on the identification of a subject's IL-1 haplotype and genotype pattern, which plays a crucial role in understanding and treating osteoporosis.

Latest Patents

Paul Martha holds 1 patent for his invention titled "Diagnostics and therapeutics for osteoporosis." This patent outlines methods for diagnosing and treating osteoporosis based on genetic markers, providing a new avenue for personalized medicine in this area.

Career Highlights

Throughout his career, Paul has been associated with Interleukin Genetics, Inc., where he has been able to apply his research in a practical setting. His work has contributed to advancements in the understanding of osteoporosis and its treatment options.

Collaborations

Paul Martha has collaborated with esteemed colleagues such as Kenneth S. Kornman and Gordon W. Duff. These partnerships have enhanced the research and development of innovative solutions in the field of osteoporosis.

Conclusion

In summary, Paul Martha is a dedicated inventor whose work in osteoporosis diagnostics and therapeutics has the potential to significantly impact patient care. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…